Live feed07:00:00·2dPRReleaseFoundation Medicine Expands Existing Collaboration with Bristol Myers Squibb to Develop a Next-Generation Sequencing Companion Diagnostic to Identify Patients with Homozygous MTAP DeletionBMY· Bristol-Myers Squibb CompanyHealth CareOriginal source
